The therapeutic potential of insulin-mimetic vanadium complexes

Bibliography

• BANTING FG, BEST CH: The internal secretion of the pancreas.' Lab. Clin. Med. (1922) 7:251–266.
   Google Scholar
• ••The first report on the discovery of insulin in the pancreas.
   Google Scholar
• LYONNET B, MARTZ X, MARTIN E: L'emploi thérapeutique des derives du vanadium. Presse Med. (1899) 1(32):191–192.
   Google Scholar
• •The first paper to describe the improvement effect of diabetic state in patients given oral sodium vanadate before the discovery of insulin.
   Google Scholar
• MEYEROVITCH J, FARFEL Z, SACK J, SHE CHTER Y: Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Biol. Chem. (1987) 262(14):6658–6662.
   Web of Science ®Google Scholar
• ••The first paper that reported the effectiveness of oral vanadate ion dissolved in drinking water to lower the high blood glucose level of model rats of Type 2 DM.
   Google Scholar
• PEDERSON RA, RAMANADHAM S, BUCHAN AMJ, MCNEILL JH: Long-term effects of vanadyl treatment on streptozotocin-induced diabetes in rat. Diabetes (1989) 38(11):1390–1395.
   PubMed Web of Science ®Google Scholar
• ••The first report on the effectiveness of vanadyl ion in improving animal DM.
   Google Scholar
• THOMPSON KH, MCNEILL JH, ORVIG C: Vanadium complexes as insulin mimics. Chem Rev (1999) 99(9):2561–2571.
   PubMed Web of Science ®Google Scholar
• THOMPSON KH, ORVIG C: Design of vanadium compounds as insulin enhancing agents.j Chem. Soc. Dalton Trans. (2000) 99(17):2885–2892.
   Google Scholar
• SAKURAI H: A new concept: The use of vanadium complexes in the treatment of diabetic mellitus. Chem. Rec. (2002) 2(4):237–248.
   PubMed Web of Science ®Google Scholar
• SAKURAI H, KOJIMA Y, YOSHIKAWA Y, KAWABE K, YASUI H: Antidiabetic vanadium(IV) and zinc (II) complexes. Coord. Chem. Rev (2002) 226(1-2):187–198.
   Web of Science ®Google Scholar
• WHO: Diabetes mellitus; Report of a WHO study group. WHO Technical Report Series. (1985) 727:91–113.
   Google Scholar
• CHASTEEN ND: The biochemistry of vanadium. Struc. Bonding (1983) 53:105–138.
   Web of Science ®Google Scholar
• KUSTIN K, MACARA IG: The new biochemistry of vanadium. Comments Inorg. Chem. (1982) 2(1-2):1–22.
   Google Scholar
• REHDER D: Inorganic consideration on the function of vanadium in biological systems. In: Vanadium and its Roles M Life. Metal Ions M Biological Systems (Volume 31). H Siegel, A Siegel (Eds), Marcel Dekker, New York (1995):1–43.
   Google Scholar
• STERNA, YIN X, TSANG SS, DAVISON A, MOON J: Vanadium as a modulator of cellular regulatory cascades and oncogene expressions. Biochem. Cell Biol. (1993) 71(3-4):103–112.
   PubMed Web of Science ®Google Scholar
• HOPKINS LL Jr, MOHR HE: The biological essentiality of vanadium. In: Newer Trace Elements W Mertz, WE Cornatze (Eds), Marcel Dekker, New York (1971):195–213.
   Google Scholar
• NIELSEN FH, OLLERICH DA: Studies on vanadium deficiency in chicks. Fed. Proc. (1973) 32(3):929.
   Google Scholar
• BUTLER A, CARTEN JN, SIMPSON MT: Vanadium in proteins and enzymes. In: Handbook on Metalloproteins. I Bertini, A Sigel, H Sigel (Eds), Marcel Dekker, New York (2001):153–179.
   Google Scholar
• WEVER R, HEMRIKA W: Chapter 12. In: Vanadium M the Environment, Part One: Chemistry and Biochemistry JO Nriagu (Ed.), John Wiley & Sons, New York (1998).
   Google Scholar
• SAKURAI H, TSUCHIYA K, NUKATSUKA M et al.: Insulin-mimetic action of vanadyl complexes." Clin. Biochem. Num. (1990) 8(3):193–200.
   Google Scholar
• ••The first report on the finding of orally active vanadyl complexes in treating DM in rats.
   Google Scholar
• THOMPSON KH, TSUKADA Y, XU Z, BATEII M, MCNEILL JH, ORVIG C: Influence of chelation and oxidation state on vanadium bioavailability, and their effects on tissue concentrations of zinc, copper, and iron. Biol. Trace Elem. Res. (2002) 86(1):31–44.
   PubMed Web of Science ®Google Scholar
• HUDSON FTG: Vanadium: Toxicology and Biochemical Significance. Elsevier, New York (1964):140.
   Google Scholar
• NIELSEN FH: Importance of making dietary recommendations for elements designated as nutritionally beneficial, pharmacologically beneficial, or conditionally essential.' Trace Elem. Exp. Med. (2000) 13(1):113–129.
   Google Scholar
• BRICHARD SM, HENQUIN JC: The role of vanadium in the management of diabetes. Trends Pharmacol. Sci. (1995) 16(8):265–270.
   PubMed Web of Science ®Google Scholar
• CANTLEY LC Jr, JOSEPSON L, WARNER R, YANAGISAWA M, LECHENE C, GUIDOTTI G: Vanadate is a potent (Na+, K±)-ATPase inhibitor found in ATP derived from muscle. I Biol. Chem. (1977) 252(21):7421–7423.
   Web of Science ®Google Scholar
• •The first finding of vanadate ion in inhibiting (Nat, 10-ATPase.
   Google Scholar
• SAKURAI H, NISHIDA M, KOYAMA M, TAKADA J: Occurrence of vanadium ions in serum albumins. Biochim. Biophys. Acta (1987) 924(3):562–563.
   PubMed Web of Science ®Google Scholar
• SAKURAI H, NISHIDA M, KIDA K, KOYAMA M, TAKADA J: Determination and characterization of vanadium ion in serum albumins. Inorg. Chim. Acta (1987) 138(2):149–153.
   Web of Science ®Google Scholar
• FANTUS IG, LAI DR, TANG S: Modulation of insulin action by vanadate: evidence of a role for phosphotyrosine phosphatase activity to alter cellular signaling. Ma Cell. Biochem. (1995) 153(1&2):103–112.
   Google Scholar
• TSIANI E, BOGDANOVIC E, SORISKY A, NAGY L, FANTUS IG: Tyrosine phosphatase inhibitors, vanadate and pervanadate, stimulate glucose transport and GLUT translocation in muscle cells by a mechanism independent of phosphatidylinositol 3-kinase and protein kinase C. Diabetes (1998) 47(11):1676–1686.
   PubMed Web of Science ®Google Scholar
• SHAFRIR E, SPIELMAN S, NACHLIEL I, KHAMAISI M, BAR-ON H, ZIV E: Treatment of diabetes with vanadium salts: general overview and amelioration of nutritionally induced diabetes in the Psammomys obesus Diabetes Metab. Res. (2001) 17(1):55–66.
   Google Scholar
• SAKURAI H, SHIMOMURA S, FUKUZAWA K, ISHIZU K: Detection of oxovanadium(IV) and characterization of its ligand environment in subcellular fractions of the liver of rats treated with pentavalent vanadium(V). Biochem. Biophys. Res. Commun. (1980) 96(1):293–298.
   PubMed Web of Science ®Google Scholar
• SAKURAI H, TSUCHIYA K, NUKATSUKA M, SOFUE M, KAWADA J: Insulin-like effect of vanadylion on streptozotocin-induced diabetic rats. .1 Endocrinol (1990) 126(3):451–459.
   Google Scholar
• NAKAI M, WATANABE H, FUJI WARA C et al.: Mechanism on insulin-like action of vanadyl sulfate: Studies on interaction between rat adipocytes and vanadium compounds. Biol. Chem. Bull. (1995) 18(5):719–725.
   Google Scholar
• SAKURAI H, HAMADA Y, SHIMOMURA S, YAMASHITA S, ISHIZU K: Cysteine methyl ester-oxovanadium(IV) complex, preparation and characterization. Lim& Chim. Acta (1980) 46(6)1119–L120.
   Google Scholar
• SAKURAI H, TAIRA Z, SAKAI N: Crystal structure of an L-cysteine methyl ester-vanadyl(IV) complex. Inorg. Chim. Acta (1988) 151(2):85–86.
   Web of Science ®Google Scholar
• PEARSON RG: Hard and soft acids and bases. " Am. Chem. Soc. (1963) 85(22)3533–3539.
   Google Scholar
• CAM MC, CROS GH, SERRANO JJ, LAZARO R, MCNEILL JH: ha vivo antidiabetic actions of naglivan, an organic vanadyl compound in streptozotocin-induced diabetes. Diab. Res. Clin. Pract. (1993) 20(2):89–91.
   PubMed Web of Science ®Google Scholar
• WATANABE H, NAKAI M, KOMAZAWA K, SAKURAI H: A new orally active insulin mimetic vanadyl complex: Bis(pyrrolidine-N-carbodithioato)oxovanadium(IV). " Med. Chem. (1994) 37(7):876–877.
   Google Scholar
• SAKURAI H, WATANABE H, TAMURA H, YASUI H, MATSUSHITA R, TAKADA J: Insulin- mimetic vanadyl-dithiocarbamate complexes. Inorg. Chim. Acta (1998) 283(1):175–183.
   Web of Science ®Google Scholar
• SAKURAI H, SANO H, TAKINO T, YASUI H: A new type of orally active insulin-mimetic vanadyl complex: Bis(1-oxy-2-pyridinethiolato)oxovanadium (IV) with VO(S202) coordination mode. Chem. Lett. (1999) (9):913–914.
   Google Scholar
• SAKURAI H, SANO H, TAKINO T, YASUI H: An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato)oxovanadium(IV), with VO(S202) coordination mode; M vitro and in vivo evaluation in rats.' Inorg. Biochem. (2000) 80(1–2):99–105.
   Google Scholar
• TAKESHITA S, KAWAMURA I, YASUNO T et al.: Amelioration of insulin resistance in diabetic ob/ob mice by a new type of orally active insulin-mimetic vanadyl complex: Bis(1-oxy-2-pyridinethiolato)oxovanadium(Iv) with VO(S202) coordination mode. I Inorg. Biochem. (2001) 85(2-3):179–186.
   PubMed Web of Science ®Google Scholar
• MCNEILL JH, YUEN VG, HOVEYDA HR, ORVIG C: Bis(maltolato)oxovanadium(IV) is a potent insulin mimetic. I Med. Chem. (1992) 35(8):1489–1491.
   PubMed Web of Science ®Google Scholar
• YUEN VG, ORVIG C, MCNEILL JH: Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV). Can. .1 Physiol. Pharmacol. (1993) 71(3-0263–269.
   Google Scholar
• YUEN VG, ORVIG C, THOMPSON KH, MCNEILL JH: Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV). Can. Physiol. Pharmacol. (1993) 71(3-0270–276.
   Google Scholar
• DIKANOV SA, LIBOIRON BD, THOMPSON KH et al.: In vivo electron-echo envelope modulation (ESEEM) spectroscopy: First observation of vanadyl coordination to phosphate in bone. Am. Chem. Soc. (1999) 121(47):11004–11005.
   Web of Science ®Google Scholar
• RANGEL M, TAMURA A, FUKUSHIMA C, SAKURAI H: In vitro study of the insulin-like action of vanadyl-pyrone and -pyridone complexes with a V0(04) coordination mode. I Biol. Inorg. Chem. (2001) 6(2):128–132.
   PubMed Web of Science ®Google Scholar
• KATOH A, TANIGUCHI K, OKUDA H et at Synthesis of new vanadyl complexes of hydroxyazine-type heterocycles and their insulin-mimetic activities. Chem. Lett. (2000) (8):866–867.
   Google Scholar
• KAWABE K, TAD OKORO M, KOJIMA Y, FUJISAWA Y, SAKURAI H: Syntheses, structures, and insulin-like activities of two vanadyl complexes; WO(GeG)(H20)1 and WO(MeM)(H20)1. Chem. Lett. (1998) (1):9–10.
   Google Scholar
• KAWABE K, TAD OKORO M, ICHIMURA A, KOJIMAY, TAKINOT, SAKURAI H: Stereospecific and structure-dependent insulin-mimetic oxovanadium(IV) complexes with Al N-ethylenebis(amino acids). Am. Chem. Soc. (1999) 121(307937–7938.
   Web of Science ®Google Scholar
• KAWABE K, SUEKUNI T, INADA T et al: Syntheses, structures, and insulin-like activities of oxovanadium(IV) complexes with tetra- and penta-dentate histidine derivatives. Chem. Lett. (1998) (11):1155–1156.
   Google Scholar
• SAKURAI H, TAMURA A, FUGONO J, YASUI H, KISS T: New Antidiabetic vanadyl-pyridone complexes: Effect of equivalent transformation of coordinating atom in the ligand. Coord. Chem. Rev (2003) (In press).
   Google Scholar
• GOLDWASER I, LI J, GERSHONOV E et al.: L-Glutamic acid y-monohydroxamate, a potentiator of vanadium-evoked glucose metabolism M vitro and in vivo. Biol. Chem. (1999) 274(37):26617–26624.
   Web of Science ®Google Scholar
• SAKURAI H, FUJII K, WATANABE H, TAMURA H: Orally active and long-term acting insulin-mimetic vanadyl complex: Bis(picolinato)oxovanadium(IV). Biochem. Biophys. Res. Commun. (1995) 214(3):1095–1101.
   PubMed Web of Science ®Google Scholar
• SAKURAI H, TAMURA A, TAKINO T, OZUTSUMI K, KAWABE K, KOJIMA Y: Interaction of vanadyl complexes with biological systems: Structure-insulinomimetic activity relationship of vanadyl-picolinate complexes. Inorg. React. Mech. (2000) 2(1-2):69–77.
   Google Scholar
• FUJIMOTO S, FUJII K, YASUI H, MATSUSHITA R, TAKADA J, SAKURAI H: Long-term acting and orally active vanadyl-methylpicolinate complex with hypoglycemic activity in streptozotocin-induced diabetic rats.' Clin. Biochem. Num. (1997) 23(2):113–129.
   Google Scholar
• TAWA R, UCHIDA K, TANIYAMA J et al.: A new insulin-mimetic cvanadyl complex, (N-pyridylmethylaspartate)oxovanadium(IV) with VO(N202) coordination mode, and evaluation of its effect on uptake of D-glucose by Ehrlich ascites. I Pharm. Pharmacol. (1999) 51(2):119–124.
   PubMed Web of Science ®Google Scholar
• TAKINO T, YASUI H, YOSHITANE A et al.: A new halogenated antidiabetic vanadyl complex, bis(5-iodopicolinato) oxovanadium(IV): M vitro and in vivo insulinomimetic evaluations and metallokinetic analysis. I Biol. Inorg. Chem. (2001) 6(2):133–142.
   PubMed Web of Science ®Google Scholar
• FUJISAWA Y, SAKURAI H: Evidence for the improvement of noninsulin-dependent diabetes mellitus in KKAY mice with daily oral administration of bis(6-methylpicolinato) oxovanadium (IV) complex. Chem. Pharm. Bull. (1999) 47(11):1668–1670.
   PubMed Web of Science ®Google Scholar
• SASAGAWA T, YOSHIKAWA Y, KAWABE K, SAKURAI H, KOJIMA Y: Bis(6-ethylpicolinato)oxovanadium(IV) complex with normoglycemic activity in KK-AY mice. I Inorg. Biochem. (2002) 88(1):108–112.
   PubMed Web of Science ®Google Scholar
• WOOL, YUEN V, THOMPSON KH, MCNEILL JH, ORVIG C: Vanadyl-biguanide complexes as potential synergistic insulin mimics. I Inorg. Biochem. (1999) 76(3-4):251–257.
   PubMed Web of Science ®Google Scholar
• INOHARA T, KAWABE K, SAKURAI H: Insulin-like action of vanadyl-porphyrin complexes. 52th Kinki Branch Conference of Pharmaceutical Society &Japan, Osaka, Japan (2002):160 (Abstract).
   Google Scholar
• SETYAWATI IA, THOMPSON KH, SUN Y et al.: Kinetic analysis and comparison of uptake, distribution, and excretion of 48V-labeled compounds in rats. Appl. Physiol. (1998) 84(2): 569–575.
   PubMed Web of Science ®Google Scholar
• KISS E, GARRIBBA E, MICERA G, KISS T, SAKURAI H: Ternary complex formation between VO(IV)-picolinic acid or VO (IV) -6-methylpicolinic acid and small blood serum bioligands. I Inorg. Biochem. (2000) 78(2):97–108.
   PubMed Web of Science ®Google Scholar
• KISS T, KISS E, GARRIBBA E, SAKURAI H: Speciation of insulin-mimetic VO aV)-containing drugs in blood serum. I Inorg. Biochem. (2000) 80(1-2):65–73.
   PubMed Web of Science ®Google Scholar
• FUKUI K, OHYA-NISHIGUCHI H, NAKAI M, SAKURAI H, KAMADA H: Detection of vanadyl-nitrogen interaction in organs of the vanadyl-treated rat: Electron spin echo envelope modulation study. FEBS Lett. (1995) 368(1):31–35.
   PubMed Web of Science ®Google Scholar
• •The first report on the binding of the vanadyl complexes in organs of rats given 1202 insulinomimetic vanadyl complexes by pulse EPR method.
   Google Scholar
• FUKUI K, FUJISAWA Y, OHYA-NISHIGUCHI H, KAMADA H, SAKURAI H: In vivo coordination structural changes of a potent insulin-mimetic agent, bis(picolinato) oxovanadium(IV), studied by electron spin-echo envelope modulation spectroscopy. Biochem. 77(3-4):215–224 (1999).
   Google Scholar
• YASUI H, TAMURA A, TAKINOT, SAKURAI H: Structure-dependent metallokinetics of Antidiabetic vanadyl-picolinate complexes in rats: Studies on solution structure, insulinomimetic activity, and metallokinetics.Biochem. (2002) 91(1):327–338.
   Google Scholar
• •The first real-time pharmacokinetic study of vanadyl state in the blood of live rats given vanadyl comlexes.
   Google Scholar
• FUGONO J, YASUI H, SAKURAI H: Pharmacokinetic study on gastrointestinal absorption of insulinomimetic vanadyl complexes in rats by ESR spectroscopy. Pharin. Phannacel (2001) 53(9):1247–1255.
   PubMed Web of Science ®Google Scholar
• REHDER D, PESSOA JC, GERALDES CF et al: In vitro study of the insulin-mimetic behavior of vanadium (IV, V) coordination compounds. .1 Biel Chem. (2002) 7(4–5):384–396.
   Google Scholar
• CRANS DC: Chemistry and insulin-like properties of vanadium(IV) and vanadium (V) compounds. .1 Inorg. Biochem. (2000) 80(1–2):123–131.
   Google Scholar
• CUSI K, CUKIER S, DEFRONZO RA et al.: Vanadyl sulfate improves hepatic and muscle insulin sensitivity in Type 2 diabetes. Clin. Endocrine]. Metab. (2001) 86(3):1410–1417.
   PubMed Web of Science ®Google Scholar
• FUGONO J, YASUI H, SAKURAI H: Enteric-coating capsulation of insulinomimetic vanadyl sulfate enhances bioavailability of vanadyl species in rats. Pharm. Pharmacy]. (2002) 54(5):611–615.
   PubMed Web of Science ®Google Scholar
• GOLDFINE AB, SIMONSON DC, FOLLI F, PATTI ME, KAHN CR: Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and M vitro studies. j. Clin. Endocrine]. Metab. (1995) 80(11):3311–3320.
   PubMed Web of Science ®Google Scholar
• DUNAI N, SAMINATHAN G: Insulin-like effects of bis-salicylidine ethylenediiminato oxovanadium(Iv) complex on carbohydrate metabolism. Biochem. Nutr. (1997) 22(1):31–39.
   Web of Science ®Google Scholar
• REUL BA, AMIN SS, BUCHED JP et al.:Effect of vanadium complexes with organic ligands on glucose metabolism: A comparison study in diabetic rats. &J. Pharmacel (1999) 126(2):467–477. Affiliation
   Google Scholar